VitaGraft Kidney Expands Utility in Recurrent Primary Diseas

VitaGraft Kidney Expands Utility in Recurrent Primary Disease Patients

25.07.2023 - - Blood-based test differentiates between ABMR and IgAN, enabling faster and more effective treatment- Improved utility over standard of care tests- Paper published in peer-reviewed journal IRVINE, Calif., July 25, 2023 (GLOBE NEWSWIRE) - ... Seite 1

Related Keywords

Berlin , Germany , Ekke Schuetz , Klemens Budde , Department Of Nephrology At Charit , Moldx Program , Vitagraft Kidney , Oncocyte ,

© 2025 Vimarsana